The reactivity of cysteines of 3CLpro affects the oligomerization state of the Sars-CoV-2 protease

被引:0
|
作者
Cipollone, I. [1 ]
Iacobucci, I. [1 ]
Cozzolino, F. [1 ]
Morasso, S. [2 ]
Storici, P. [2 ]
Iaconis, D. [3 ]
Talarico, C. [3 ]
Manelfi, C. [4 ]
Beccari, A. [3 ]
Monti, M. [1 ]
机构
[1] Univ Naples Federico II, Naples, Italy
[2] Elettra Sincrotrone Trieste, Trieste, Italy
[3] Dompe Farmaceut SpA, Naples, Italy
[4] Dompe Farmaceut SpA, Laquila, Italy
来源
FEBS OPEN BIO | 2024年 / 14卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P-34-024
引用
收藏
页码:422 / 422
页数:1
相关论文
共 50 条
  • [31] Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CLpro inhibitors
    Wang, Feng
    Liu, Donglan
    Gao, Dingding
    Yuan, Jinwei
    Zhao, Jingxian
    Yuan, Shuai
    Cen, Yixin
    Lin, Guo-Qiang
    Zhao, Jincun
    Tian, Ping
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 264
  • [32] Exploration of chalcones as 3-chymotrypsin-like protease (3CLpro) inhibitors of SARS-CoV-2 using computational approaches
    Thua-Phong Lam
    Dac-Nhan Nguyen
    Tan Thanh Mai
    Thanh-Dao Tran
    Minh-Tri Le
    Phuong Nguyen Hoai Huynh
    Duc-Tuan Nguyen
    Viet-Hung Tran
    Dieu-Thuong Thi Trinh
    Phuong Truong
    Cam-Van T Vo
    Khac-Minh Thai
    STRUCTURAL CHEMISTRY, 2022, 33 (05) : 1707 - 1725
  • [33] Exploration of chalcones as 3-chymotrypsin-like protease (3CLpro) inhibitors of SARS-CoV-2 using computational approaches
    Thua-Phong Lam
    Dac-Nhan Nguyen
    Tan Thanh Mai
    Thanh-Dao Tran
    Minh-Tri Le
    Phuong Nguyen Hoai Huynh
    Duc-Tuan Nguyen
    Viet-Hung Tran
    Dieu-Thuong Thi Trinh
    Phuong Truong
    Cam-Van T. Vo
    Khac-Minh Thai
    Structural Chemistry, 2022, 33 : 1707 - 1725
  • [34] Human Superantibodies to 3CLpro Inhibit Replication of SARS-CoV-2 across Variants
    Glab-ampai, Kittirat
    Kaewchim, Kanasap
    Saenlom, Thanatsaran
    Thepsawat, Watayagorn
    Mahasongkram, Kodchakorn
    Sookrung, Nitat
    Chaicumpa, Wanpen
    Chulanetra, Monrat
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [35] SARS-CoV-2 3CLpro displays faster self-maturation in vitro than SARS-CoV 3CLpro due to faster C-terminal cleavage
    Kuo, Chih-Jung
    Liang, Po-Huang
    FEBS LETTERS, 2022, 596 (09) : 1214 - 1224
  • [36] Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations
    Grottesi, Alessandro
    Besker, Neva
    Emerson, Andrew
    Manelfi, Candida
    Beccari, Andrea R.
    Frigerio, Francesco
    Lindahl, Erik
    Cerchia, Carmen
    Talarico, Carmine
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 18
  • [37] Comparative protein structure network analysis on 3CLpro from SARS-CoV-1 and SARS-CoV-2
    Lata, Surabhi
    Akif, Mohd.
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2021, 89 (09) : 1216 - 1225
  • [38] Virtual screening of approved clinic drugs with main protease (3CLpro) reveals potential inhibitory effects on SARS-CoV-2
    Wang, Qiang
    Zhao, Ying
    Chen, Xiaojia
    Hong, An
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (02): : 685 - 695
  • [39] Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs
    Rizzuti, Bruno
    Grande, Fedora
    Conforti, Filomena
    Jimenez-Alesanco, Ana
    Ceballos-Laita, Laura
    Ortega-Alarcon, David
    Vega, Sonia
    Reyburn, Hugh T.
    Abian, Olga
    Velazquez-Campoy, Adrian
    BIOMEDICINES, 2021, 9 (04)
  • [40] Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach
    Gupta, Yash
    Kumar, Sumit
    Zak, Samantha E.
    Jones, Krysten A.
    Upadhyay, Charu
    Sharma, Neha
    Azizi, Saara-Anne
    Kathayat, Rahul S.
    Poonam
    Herbert, Andrew S.
    Durvasula, Ravi
    Dickinson, Bryan C.
    Dye, John M.
    Rathi, Brijesh
    Kempaiah, Prakasha
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 47